Suitability Petition to FDA

Hyman, Phelps & McNamara, P.C. submitted a Suitability Petition to the FDA seeking approval for a proposed drug product change under the applicable regulatory framework. The petition was filed in docket FDA-2026-P-4020-0001 and directed to CDER for review and disposition.

Pharmaceutical companies and sponsors monitoring this docket should track FDA's response to the petition, as suitability petitions can affect pending or future drug product approval pathways. Interested parties may submit comments or supporting documentation as appropriate.